Key result
Prior cancer history linked to ~70% higher risk of major cardiovascular events in chest pain.
Why the study?
To examine the association between a personal history of cancer and the likelihood of a cardiovascular diagnosis among patients presenting with chest pain.
Does a personal history of cancer increase the risk of a cardiovascular diagnosis in adults presenting with chest pain?
Cohort (n=37,819)
No
Does a personal history of cancer increase the risk of a cardiovascular diagnosis in adults presenting with chest pain?
Odds Ratio: 1.7 (95% CI 1.5–2)
Absolute Event Rate: 18% vs 8%
p-value: p=<0.001
Cancer survivors presenting with chest pain have a significantly higher risk of acute cardiovascular events and long-term mortality, highlighting the need for heightened clinical suspicion and tailored risk stratification.
Cancer survivors with chest pain may warrant closer evaluation; leaves open whether targeted strategies improve outcomes.
Aims To examine the association between a personal history of cancer and the likelihood of a cardiovascular diagnosis among patients presenting with chest pain. Methods and results We analyzed data from consecutive adult patients hospitalized with a primary diagnosis of chest pain between 2007 and 2022, excluding those with active cancer or ST-elevation myocardial infarction. Patients were categorized into two groups: cancer survivors and other patients. The primary outcome was a cardiovascular probable diagnosis, defined as a composite of non-ST-segment elevation myocardial infarction, pulmonary embolism, new-onset atrial fibrillation, or mortality within 30 days. The final cohort included 37 819 patients with a median age of 65 years (Q1–Q3: 55–75), of whom 24 644 (65%) were men. Among these, 1838 (5%) had a history of cancer. A multivariable logistic regression model demonstrated that cancer survivors were 70% more likely to reach the study primary endpoint compared with other patients (P < 0.001). A propensity score matching model consistently demonstrated that cancer survivors were 40% more likely to meet the study endpoint (95% CI 1.2–1.7, P < 0.001). Over a median follow-up of 4.3 years (Q1–Q3: 2.1–7.3), 7035 (19%) patients died. Kaplan-Meier survival analysis indicated a cumulative probability of death of 29% ± 22% for cancer survivors vs. 12% ± 9% for other patients (P < 0.001, Log rank). Conclusion Among patients admitted to the hospital with chest pain, a personal history of cancer is independently associated with a significantly higher likelihood of receiving a final cardiovascular diagnosis.
No takes yet. Share an insight, caveat, or question.
Faierstein et al. (2025) conducted a cohort in Chest pain (n=37,819). Personal history of cancer vs. No history of cancer was evaluated on Composite of non-ST-segment elevation myocardial infarction, pulmonary embolism, new-onset atrial fibrillation, or mortality within 30 days (OR 1.7, 95% CI 1.5-2.0, p=<0.001). A personal history of cancer was associated with a 70% increased risk of a composite cardiovascular diagnosis (OR 1.7) among patients presenting with chest pain.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: